AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-2.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$67.2M
(+1.8%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
29.38%
Holding
407
New
72
Increased
86
Reduced
65
Closed
155
Top Buys
| 1 |
Alkermes
ALKS
|
$48.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$45.5M |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$37.9M |
| 4 |
Simply Good Foods
SMPL
|
$34.6M |
| 5 |
Immunovant
IMVT
|
$32.5M |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$92.8M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$38.2M |
| 3 |
Coca-Cola
KO
|
$37M |
| 4 |
argenx
ARGX
|
$27.5M |
| 5 |
Post Holdings
POST
|
$26.8M |
Sector Composition
| 1 | Healthcare | 68.75% |
| 2 | Consumer Staples | 10.83% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Technology | 7.69% |
| 5 | Materials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
DTE Energy
DTE
$28.4B
| $223K | ﹤0.01% |
+2,009
| New | +$223K |
|
202
Cyclacel Pharmaceuticals
CYCC
$15.9M
| $217K | ﹤0.01% |
+558
| New | +$217K |
|
203
Abercrombie & Fitch
ANF
$4.49B
| $216K | ﹤0.01% |
1,213
-3,309
| -73% | -$588K |
|
|
DBGI
204
Digital Brands Group, Inc. Common Stock
DBGI
$38M
| $215K | ﹤0.01% |
+2,940
| New | +$215K |
|
205
Elanco Animal Health
ELAN
$9.16B
| $214K | ﹤0.01% |
14,811
-11,714
| -44% | -$169K |
|
|
GENE
206
DELISTED
Genetic Technologies Ltd.
GENE
| $210K | ﹤0.01% |
+140,000
| New | +$210K |
|
207
Soligenix
SNGX
$9.34M
| $206K | ﹤0.01% |
+80,000
| New | +$206K |
|
|
BPTH
208
DELISTED
Bio-Path Holdings Inc
BPTH
| $194K | ﹤0.01% |
+97,000
| New | +$194K |
|
209
Hoth Therapeutics
HOTH
$17.6M
| $194K | ﹤0.01% |
213,000
-197,000
| -48% | -$179K |
|
|
FGIWW
210
FGI Industries Ltd. Warrant
FGIWW
| $176K | ﹤0.01% |
933,333
| – | – |
|
211
Cingulate
CING
$21.1M
| $157K | ﹤0.01% |
+40,833
| New | +$157K |
|
|
ENTO
212
Entero Therapeutics
ENTO
$4.29M
| $155K | ﹤0.01% |
42,000
+33,000
| +367% | +$122K |
|
213
PainReform
PRFX
$2.86M
| $132K | ﹤0.01% |
11,500
+5,000
| +77% | +$57.6K |
|
214
Helius Medical Technologies
HSDT
$6.4M
| $127K | ﹤0.01% |
+173
| New | +$127K |
|
215
Palisade Bio
PALI
$5.84M
| $125K | ﹤0.01% |
27,858
-20,142
| -42% | -$90.6K |
|
216
Goodyear
GT
$2.43B
| $114K | ﹤0.01% |
10,049
-21,871
| -69% | -$248K |
|
|
NXLIW
217
Nexalin Technology, Inc. Warrant
NXLIW
$44K
| $111K | ﹤0.01% |
325,000
| – | – |
|
|
BCTXW
218
BriaCell Therapeutics Corp. Warrant
BCTXW
$90.8K
| $101K | ﹤0.01% |
375,000
| – | – |
|
219
Onfolio Holdings Inc. Warrant
ONFOW
$1.44M
| $99.5K | ﹤0.01% |
400,000
| – | – |
|
|
STKH
220
Steakholder Foods
STKH
$2.83M
| $98.8K | ﹤0.01% |
5,364
-142,518
| -96% | -$2.62M |
|
221
Hudbay
HBM
$5.03B
| $97.5K | ﹤0.01% |
+10,770
| New | +$97.5K |
|
222
GRI Bio
GRI
$4.18M
| $96.4K | ﹤0.01% |
+2,953
| New | +$96.4K |
|
223
NanoVibronix
NAOV
$4.14M
| $95.8K | ﹤0.01% |
1,244
-1,037
| -45% | -$79.9K |
|
224
Maris-Tech Ltd. Warrants
MTEKW
$2.15M
| $94.6K | ﹤0.01% |
1,261,058
| – | – |
|
225
Sharps Technology Inc. Warrant
STSSW
$588K
| $85.8K | ﹤0.01% |
1,176,000
| – | – |
|